NEW VENTURETEC provides a unique direct investment access into early stage, high quality US companies in the areas of Biotechnology and Technology with the objective - to achieve substantial capital appreciation on investments for shareholders through active involvement in a number of well selected venture companies; - to diversify early stage investments at a broad based technology forefront with an entrepreneurial approach. Investment Philosophy Investments are being made after thorough analysis of potentially high quality companies in growing markets. They are actively managed and monitored. Milestones are being set, and management is being reviewed. Investment Manager Peter Friedli has been a principal of the investment banking firm Friedli corporate Finance since 1986. Mr. Friedli has over 21 years of entrepreneurial experience as an independent investment manager in venture capital and has specialized in investments predominantly domiciled in the United States in the areas of biotechnology and technology. He has held interests in more than 170 venture companies ranging from start-up to public companies. Peter Friedli possesses an active involvement in the management of a number of those companies and also serves on the board of them. Prior thereto, he worked in the field of international management consulting for service and industrial companies in Europe an the United States.